U.S. markets closed
S&P Futures
3,841.50+2.50(+0.07%)Dow Futures
31,539.00+74.00(+0.24%)Nasdaq Futures
12,625.00-38.75(-0.31%)
ImmunoCellular Therapeutics, Ltd. (IMUC)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.7500-0.0600 (-7.41%)
At close: 3:44PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD
Valuation Measures
Premium required to access annual data
Annual
Quarterly
Premium required to access monthly dataMonthly
Subscribe to Premium to download historical data| Â | As of Date: 2/14/2021Current |
|---|---|
| Market Cap (intraday) 5 | 1.16M |
| Enterprise Value 3 | -1.69M |
| Trailing P/E | 0.02 |
| Forward P/E 1 | N/A |
| PEG Ratio (5 yr expected) 1 | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.35 |
| Enterprise Value/Revenue 3 | N/A |
| Enterprise Value/EBITDA 6 | 0.30 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.50 |
| 52-Week Change 3 | 59.57% |
| S&P500 52-Week Change 3 | 39.88% |
| 52 Week High 3 | 0.9800 |
| 52 Week Low 3 | 0.3900 |
| 50-Day Moving Average 3 | 0.6985 |
| 200-Day Moving Average 3 | 0.6615 |
Share Statistics
| Avg Vol (3 month) 3 | 33.92k |
| Avg Vol (10 day) 3 | 10.03k |
| Shares Outstanding 5 | 4.19M |
| Float | 4.18M |
| % Held by Insiders 1 | 0.00% |
| % Held by Institutions 1 | 0.00% |
| Shares Short (Oct 14, 2018) 4 | 165.95k |
| Short Ratio (Oct 14, 2018) 4 | 4.13 |
| Short % of Float (Oct 14, 2018) 4 | 3.96% |
| Short % of Shares Outstanding (Oct 14, 2018) 4 | 3.96% |
| Shares Short (prior month Sep 13, 2018) 4 | 147.78k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Sep 15, 2020 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Sep 15, 2020 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2017 |
| Most Recent Quarter (mrq) | Jun 29, 2018 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -88.07% |
| Return on Equity (ttm) | -2,312.00% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -6.07M |
| Net Income Avi to Common (ttm) | -9.03M |
| Diluted EPS (ttm) | -2.6900 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.85M |
| Total Cash Per Share (mrq) | 0.68 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 9.53 |
| Book Value Per Share (mrq) | 0.82 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10.93M |
| Levered Free Cash Flow (ttm) | -9.22M |
© 2021 Verizon Media. All rights reserved.
